Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlie Strange

Showing results (121-130 of 200) with videos related to

Pageof 20
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|February 18, 2022
PRIMUS - Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD ExacerbationJoseph Tkacz, Kristin A Evans, Daniel R Touchette, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 12, 2005
Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiencyChristopher L Bowlus, Ira Willner, Mark A Zern, et al.
BMJ Open Respiratory Research|November 18, 2025
Matrix metalloproteinases and disease severity among PI*MZ and PI*ZZ individuals in the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) cohortVickram Tejwani, Russell P Bowler, Karina A Serban, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|June 1, 2026
Gene Therapy: Knowledge, Attitudes, and Preferences Among Individuals with Alpha-1 Antitrypsin DeficiencyMatthew M Stern, Kimberly E Foil, Charlie Strange, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 5, 2016
Gender and asthma-chronic obstructive pulmonary disease overlap syndromeAnne G Wheaton, Roy A Pleasants, Janet B Croft, et al.
Chest|October 10, 2008
alpha1-Antitrypsin augmentation therapy for PI*MZ heterozygotes: a cautionary noteRobert A Sandhaus, Gerard Turino, James Stocks, et al.
Respiratory Medicine|March 15, 2012
Perspectives for improving the evaluation and access of therapies for rare lung diseases in EuropeMaurizio Luisetti, Ian M Balfour-Lynn, Simon R Johnson, et al.
Chest|April 12, 2005
Mortality in individuals with severe deficiency of alpha1-antitrypsin: findings from the National Heart, Lung, and Blood Institute RegistryJames K Stoller, Joseph Tomashefski, Ronald G Crystal, et al.
The Nursing Clinics of North America|December 4, 2013
Genetics' influence on patient experiences with a rare chronic disorder: a photovoice study of living with alpha-1 antitrypsin deficiencyPamela Holtzclaw Williams, Lucinda Shore, Marvin Sineath, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|October 22, 2020
A population-based estimate of the health care burden of obstructive sleep apnea using a STOP-BAG questionnaire in South CarolinaCharlie Strange, Chelsea L Richard, Shuxiang Shan, et al.
Pageof 20

Showing results (121-130 of 200) with videos related to

Sort By:
Pageof 20
International Journal of Chronic Obstructive Pulmonary Disease|February 18, 2022
PRIMUS - Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD ExacerbationJoseph Tkacz, Kristin A Evans, Daniel R Touchette, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 12, 2005
Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiencyChristopher L Bowlus, Ira Willner, Mark A Zern, et al.
BMJ Open Respiratory Research|November 18, 2025
Matrix metalloproteinases and disease severity among PI*MZ and PI*ZZ individuals in the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) cohortVickram Tejwani, Russell P Bowler, Karina A Serban, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|June 1, 2026
Gene Therapy: Knowledge, Attitudes, and Preferences Among Individuals with Alpha-1 Antitrypsin DeficiencyMatthew M Stern, Kimberly E Foil, Charlie Strange, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 5, 2016
Gender and asthma-chronic obstructive pulmonary disease overlap syndromeAnne G Wheaton, Roy A Pleasants, Janet B Croft, et al.
Chest|October 10, 2008
alpha1-Antitrypsin augmentation therapy for PI*MZ heterozygotes: a cautionary noteRobert A Sandhaus, Gerard Turino, James Stocks, et al.
Respiratory Medicine|March 15, 2012
Perspectives for improving the evaluation and access of therapies for rare lung diseases in EuropeMaurizio Luisetti, Ian M Balfour-Lynn, Simon R Johnson, et al.
Chest|April 12, 2005
Mortality in individuals with severe deficiency of alpha1-antitrypsin: findings from the National Heart, Lung, and Blood Institute RegistryJames K Stoller, Joseph Tomashefski, Ronald G Crystal, et al.
The Nursing Clinics of North America|December 4, 2013
Genetics' influence on patient experiences with a rare chronic disorder: a photovoice study of living with alpha-1 antitrypsin deficiencyPamela Holtzclaw Williams, Lucinda Shore, Marvin Sineath, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|October 22, 2020
A population-based estimate of the health care burden of obstructive sleep apnea using a STOP-BAG questionnaire in South CarolinaCharlie Strange, Chelsea L Richard, Shuxiang Shan, et al.
Pageof 20